Gema Hernandez-Ibarburu

8PUBLICATIONS
31CO-AUTHORS
Molecular targetsGene and molecular therapyNutritional epidemiologyDisease surveillanceEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 21, 2025
Impact of Immune Checkpoint Inhibitors on Second Primary Cancer Risk in Patients With Metastatic Lung Cancer Using Real-World Data From the TriNetX Network: Retrospective Cohort Study.

Pierre Heudel, Gema Hernandez, Olivier Denquin

|Sep 19, 2025
Comparative Mortality in Heart Failure on Guideline-Directed Medical Therapy Versus Malignant Cancer: A Report From a Global Federated Research Network.

Luca Monzo, Guillaume Baudry, Kevin Duarte

|Jan 30, 2025
Long-Term Thyroid Outcomes After COVID-19 Vaccination: A Cohort Study of 2 333 496 Patients From the TriNetX Network.

Kai-Lun Cheng, Wei-Shin Yu, Yu-Hsun Wang

|Jan 25, 2025
Prevalence of Hepatitis C Virus Among Hospitalized Patients in a Tertiary Hospital in Italy: The Basis for a National Screening Assessment Model?

Giulia Morsica, Massimo Locatelli, Gema Hernandez-Ibarburu

|Nov 06, 2024
Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T.

Aikaterini Eleftheriadou, David Riley, Sizheng S Zhao

|Apr 07, 2024
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.

Aikaterini Eleftheriadou, David Riley, Sizheng S Zhao

Pageof 2

Frequent Collaborators

2 joint publications

Uazman Alam

2 joint publications

Timothy L Jackson

2 joint publications

Philip Austin

2 joint publications

Aikaterini Eleftheriadou